1/59
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
|---|
No study sessions yet.
etiologic factors for leukemia
previous radiation exposure
Down syndrome
alkylating agents
genetic - chromosome #22
chemicals - Benzene
number of lobes in each breast
15-20
risk factors for breast cancer
gender- most significant
estrogen
age
longer fertility period - early menarche and/or late menopause
socioeconomic status
dietary fat
obesity
apple shaped body > pear shaped body
no children or first child after age 35
family history
BRCA-1 or 2
Caucasian women
moderate consumption of alcohol
history of benign breast disease
ionizing radiation
previous history of cancer
hormone replacement therapy (HRT)
hypercalcemia
smoking longer than 20 years
oral contraceptives?
pathology of breast cancer
infiltrating ductal carcinoma
most common
“cancer of the breast”
tends to spread to axillary nodes
intraductal carcinoma
palpable lump, discharge from nipple (Paget’s disease), or abnormal mammogram showing clustered macrocalcifications
lobular carcinoma
occurs most often in younger premenopausal women
inflammatory carcinoma
poor prognosis
rapid growth and metastasis
considered automatic stage T4
treated with surgery, RTT, and chemo
male breast cancer
about 1% of all breast cancers
worse prognosis than for women
ER/PR status effect on breast cancer
positive = better prognosis and response to hormonal therapy (Tamoxifen)
staging for CLL
RAI staging system
stage 0: lymphocytosis only
stage 1: + lymph node enlargement
stage 2: + splenic involvement
stage 3: + anemia
stage 4: + thrombocytopenia
muscles that are contiguous or in close proximity to breast
pectoralis major/minor
serratus anterior
latissimus dorsi
percentage of women affected by breast cancer
1 in 8
reservoir via a burr hole leading to the third ventricle by which methotrexate can be introduced directly into the CNS
Ommaya
appearance of cells in acute vs chronic leukemia
acute leukemias tend to have larger, stickie cells
presentation of breast cancer
painless lump on breast - most common
nonlactational discharge from breast - 2nd most common
enlarged axillary node - occasionally the first symptom
nipple retraction/tenderness
Paget’s disease
hypercalcemia
most common location of the breast where cancers arise
upper outer quadrant, left breast
treatment techniques for breast surgery
radical mastectomy
introduced by William Halsted
removal of breast and all underlying muscle including pectoralis major/minor and axillary nodes
modified radical mastectomy AKA total mastectomy
removes all breast tissue and some or all axillary nodes
preserves as much muscle as possible
lumpectomy AKA tylectomy, wide excision, partial excision
removal of lump and axillary nodes
mammography guidelines for women
35-40: baseline
40s: every other year
50s: every year
diagnostic procedures for breast cancer
mammography
MRI
ultrasound
only type of leukemia that is still considered incurable
chronic lymphocytic lymphoma (CLL)
lymph node groups involved in breast cancer
axillary
most important
10-38 in each axilla
70% of drainage from breast
supraclavicular
internal mammary chain (IMC)
8 nodes on average w/ 4 on each side of sternum
lesions of medial and central breast area more frequently spread to what lymph node group
internal mammary chain (IMC)
flow cytometry results associated with poorer prognosis of breast cancers
aneuploid tumors
S-phase
estrogen receptors are found more commonly in what women
post-menopausal
prognostic factors for breast cancer
most important: number of positive axillary lymph nodes
>10 is poor prognosis
involvement of IMC and/or supraclavicular nodes = poor prognosis
breast cancer histology associated with symptom “Peau d’ Orange”
inflammatory carcinoma
chemotherapy agents commonly used for breast cancer
adriamycin AKA doxorubicin
cyclophosphamide AKA Cytoxan
5FU
methotrexate
megace
anti-estrogen traditionally used by patients that are positive for hormone receptors
Tamoxifen
contraindications for breast conservation treatment techniques
unfavorable breast size to tumor (large tumor in small breast)
extremely large or pendulous breasts
pregnancy
advanced disease
best energy range for breast treatment
4-8 MV
leukemia that typically presents with acute sickness, fever, anemia, etc.
acute myelogenous leukemia
leukemia in which patients undergo a “blast crisis” and almost always die unless given a BMT
chronic myelogenous leukemia (CML)
person who developed staging system for CLL
Rai
flash required on tangential fields for breast treatment
1-2 cm
dose for breast treatment
entire breast: 45-50 Gy
chestwall of post-mastectomy patient: 45-60 Gy
total w/ boost: 60-66 Gy
possible effects of irradiation to the breast
acute
erythema
fatigue
late
skin fibrosis
hyperpigmentation
edema (in ipsilateral arm)
pneumonitis - if over 25 Gy to any portion of lung
cardiac effects
brachial plexopaty
osteoradionecrosis
overall 5 year survival rate for breast cancer
80-90%
chromosome #22
AKA Philadelphia chromosome, lost in detecting CML
median survival per stage for CLL
stage 0: 11+ years
stage 1: 8 years
stage 2: 4 years
stage 3: 2 years
stage 4: 1 year
leukemia that is most common in children and referred to as “childhood”
acute lymphocytic leukemia (ALL)
leukemia that sometimes “hides” in sanctuary sites
acute lymphocytic leukemia (ALL)
Down’s syndrome is an etiological factor for which type of leukemia
acute myelogenous leukemia (AML)
nodes radiation with posterior axillary boost (PAB) field
level 3 axillary nodes
determining optimal incline angle when using a breast board for positioning
slope of chest
best technique when treating supraclavicular field along with opposing tangents
half-field technique
reason for limiting amount of lung tissue in tangential breast fields to 2 cm
to decrease risk of lung fibrosis
staging for breast cancer
American Joint Committee on Cancer (AJCC) based on TNM system
TIS: Paget’s disease of the nipple, lobular carcinoma in situ, and intraductal carcinoma in situ
T1: tumor 2 cm or less
T1a: no fixation to underlying fascia
T1b: fixation to underlying fascia
T2: tumor greater than 2 cm but less than 5 cm
T3: tumor greater than 5 cm
T4: tumor of any size with direct extension to the chest wall or skin
sentinel lymph node biopsy involves
injection of blue dye and radioactive Technetium-99m (Tc99m)
leukemia causes impairment of the body’s normal production of
red blood cells
factors that lead to failure in bone marrow transplants
recurrent disease
autologous donor
graft vs host disease
types of bone marrow transplants
autologous: using own bone marrow
allogeneic: using someone else’s bone marrow
leukemia that always involves lymphocytosis
chronic lymphocytic leukemia (CLL)
leukemia with worst prognosis
chronic myelogenous leukemia (CML)
dosimeter used to check midline doses and placed at specific areas such as patient’s ankles, knees, and thighs when treating TBI
thermoluminscent dosimeters (TLDs)
needed for definitive diagnosis for ALL
bone marrow aspiration biopsy
“generic” cell that has a lot of growth potential
stem cell
non-malignant disease resulting when a BMT patient’s body rejects the new bone marrow or immunity cells as being “foreign”
graft vs host disease (GVHD)
functional unit of the breast
lobule
treatment fields associated with breast treatment
parallel opposed tangents
supraclavicular
posterior axillary boost
internal mammary chain
“sanctuary sites” of leukemia
brain
cerebrospinal fluid (CSF)
testes
borders of breast tangential fields
medial: around mid-line, line from the SSN to xiphoid
superior: at least 2 cm superior/cephalad to the mass and as far as possible without including the arm
inferior: 1-2 cm inferior/caudal to inframammary fold
lateral: CR around mid-axillary line
anterior: 1 cm flash
pathology of breast cancer for which induction chemotherapy is given as an initial treatment
inflammatory carcinoma
German physician who coined “leukemia”
Rudolph Virchow
person who developed radical mastectomy
William Halsted